Start-Up Previews, April 2013
This Month's Profile Group: Using Quantified-Self Data To Enhance Fertility And Pregnancy, features profiles of Fertility Focus, Ovuline, and Unifvy. Plus these Start-Ups Across Health Care: Actium Biosystems, MacuLogix, Novan, and Presage Biosciences.
You may also be interested in...
The Actium Cancer Treatment System from Actium Biosystems LLC is designed to improve bladder cancer treatment by selectively heating chemotherapeutic agents within the body to drive them more deeply into tumors. Studies confirm that as much as four times the amount of drug reaches the cancer tumor with the addition of hyperthermia, compared with the standard of care for chemotherapy that does not use any heat and thus treats at the normal body temperature.
The AdaptDx from MacuLogix Inc. has the potential to be the first practical diagnostic instrument for early detection of AMD. Akin to routine peripheral vision testing for glaucoma, the noninvasive desktop device measures impaired dark adaptation (the speed with which vision is recovered when moving from a brightly lit environment to darkness), an early-stage marker of AMD development.
Univfy Inc. has developed evidence-based, personalized prediction models of in vitro fertilization treatment success for fertility patients and their health care providers, as a support tool to help increase the success of IVF, decrease dropout rates, and better assess the risks of the procedure.